SPRO
#4129
Spero Therapeutics, Inc. - Common Stock
1.2 0 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.83%
Variación mensual
0.00%
Variación en los últimos 6 meses
-43.40%
Cambio anual
-40.30%
Cierres anteriores
1.2 1
Open
1.1 9
Mínimo
1.1 9
Máximo
1.2 0
Volumen
89
Financials
- Market Capitalization 69.88 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.53
Relación precio/flujo de caja
2.06
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4127 |  CSBR Champions Oncology, Inc. - Common Stock | 4.96 USD | -1.20% | -2.17% | -7.98% | -25.64% | 68.91 M USD | ||
| 4128 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 1.12 USD | -2.61% | -2.61% | +3.70% | -30.86% | 69.35 M USD | ||
| 4137 |  IBIO iBio, Inc. - Common Stock | 1.36 USD | -2.86% | -4.90% | -2.16% | -40.87% | 67.56 M USD | ||
| 4150 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.77 USD | -1.28% | -6.10% | -1.28% | -30.02% | 66.43 M USD |